Nov 26, 2018
https://ift.tt/eA8V8J
seen from Germany
seen from India
seen from Iraq
seen from United States
seen from United Kingdom
seen from Japan
seen from Germany
seen from United States
seen from United States
seen from Japan
seen from Brazil
seen from United States
seen from Italy
seen from United Kingdom
seen from China
seen from United States
seen from United States
seen from United States
seen from Singapore
seen from Brazil
https://ift.tt/eA8V8J
WSGR 2017 Medical Device Conference
WSGR 2017 Medical Device Conference
With shrinking pool of serious early stage life science investors and stringent capital requirements, the path for medtech companies has become greatly challenging. As is the case every year, Wilson Sonsini Goodrich & Rosati 2017 Medical Device Conference provided a forum for addressing challenges faced by new medtech companies as well as opportunities presented by current trends.
Various…
View On WordPress
AdvaMed Commends March 2017 House Reconciliation Legislation
An accomplished senior executive, Stephen C. McEvoy holds a juris doctor from Columbia Law School and a master of business administration from Duke University. Currently residing in Belmont, Massachusetts, he serves as vice president, general counsel, and assistant secretary at Abiomed, Inc., in the nearby city of Danvers. Stephen C. McEvoy of Belmont concurrently sits on the legal committee of the Advanced Medical Technology Association (AdvaMed). A medical technology trade association with headquarters in Washington, DC, AdvaMed promotes ethical industry standards and easy patient access to effective healthcare products. The organization also advocates on behalf of public economic policies that promise to boost value creation in the medical technology sector. On March 7, 2017, AdvaMed and its president/CEO Scott Whitaker released a statement that praised recent reconciliation legislation in the US House of Representatives. Introduced by the House Ways and Means Committee, this legislation seeks to permanently repeal the medical device excise tax. AdvaMed contends that the repeal of this tax will create job growth as well as innovative research and development in the medical technology field, which could lead to breakthroughs in the diagnosis and treatment of multiple medical conditions. According to US Commerce Department data, the induction and enforcement of the medical device excise tax coincided with a loss of almost 29,000 American jobs.
Awesome night at the Chicago Cubs spring training home Sloan Park Mesa with a national consortium of CEO's / Executive Directors in town for a AdvaMed conference. I got a chance to talk with an AZBio exec and I am excited for all the opportunity that Mesa has in the Medical and Biotechnology sector. Osborn School Board member Ylenia Aguilar joined us. It was cool to see Scottsdale Mayor Jim Lane again also. Thank you to the City of Mesa Economic Development for setting this up. #iheartmesa #AzBio #AdvaMed (at Sloan Park Mesa)
Tecnología médica en Colombia crece en competitividad
Tecnología médica en Colombia crece en competitividad
La Cámara de Dispositivos Médicos e Insumos para la Salud de la ANDI y su homólogo en Estados Unidos, AdvaMed (Advanced Medical Technology Association) realizan La Conferencia Latinoamericana de Cumplimiento 2017; dos días de encuentros con más de 20 conferencistas nacionales e internacionales, expertos en temas de ética y políticas de buen gobierno empresarial, que discutirán los retos del…
View On WordPress
A new study undertaken by IMS Health has revealed that the price of stents in India is not the highest contributor to the overall angioplasty cost. According toIMS Health, stent prices contribute only 20 – 25% to the overall angioplasty procedure costs.
New Neurosurgery Blog Post - Cross Post – Beating Stroke: Expanding Access to Effective Treatment and Perfecting Systems of Care Delivery.
Medical device lobbyist tapped to lead PhRMA
Medical device lobbyist tapped to lead PhRMA
September 23, 2015
A medical device lobbyist is expected to take over as head of the pharmaceutical industry’s largest trade group, according to a source.
Steve Ubl, president and CEO of AdvaMed, will “more than likely” take over as president and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA), the source said.
The move is not finalized, however. PhRMA spokesman Robert…
View On WordPress